Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery India 2016

Drug Discovery India 2016 Agenda

Co-Located Conference Agendas

Antibodies and Antibody Drug Conjugates | Drug Discovery India 2016 | 

Print Agenda

Thursday, 29 September 2016

Draft Agenda- Subject to Change






Rathnam ChaguturuConference Chair

Welcome Address
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America


V NagarajaKeynote Presentation

Inaugural Talk- Targeting Topology Modulators to Counter Resurgent Tuberculosis
V Nagaraja, President, JNCASR, India


Coffee Break and Networking in the Exhibition Area

Session I: Chemical Biology Approaches in Drug Discovery / Session Chair: Dr Divakar Goli


Siddhartha RoyKeynote Presentation

Development of Peptide-based Synthetic Transcription Factors as Peptide Therapeutics
Siddhartha Roy, Former-Director, IICB; Director, Bose Institute, CSIR-Indian Institute of Chemical Biology, India


Discovery of Novel Dual ATP-Competitive Inhibitors of DNA Gyrase and Topoisomerase IV inspired by Marine Natural Compounds
Danijel Kikelj, Professor, University of Ljubljana, Slovenia


Lysine Acetylation and Arginine Methylation of Histones are critical for Neural Differentiation and Memory: Probed by Small Molecule Modulators
Tapas Kundu, Professor, JNCASR, India


System Biology Approaches in Drug Discovery
Nagasuma Chandra, Professor, Indian Institute of Science, India


Polyphenols for HIV Prophylaxis: A Journey from Discovery to Delivery
Vandana Patravale, Professor, Institute of Chemical Technology, India

This talk will discuss about potential of polyphenols as gp120-CD4 binding inhibitors for prevention of HIV transmission.


Beckman CoulterTechnology Spotlight:
Advanced Flow Cytometry Solutions and Particle Counting & Characterization in Addressing Your Essential Research Needs
Amitav Mohanty, Manager Market Development, Beckman Coulter, India
Ramanuj Samal, Application Specialist, Beckman Coulter India Pvt Ltd, India


Lunch Break and Networking in the Exhibition Area

Session II: From Natural Products to Drug Candidates / Session Chair: Dr C S Shastry


Drugs from Nature, Drugs from our Ancestors - Tradition to Evidence based Medicines
Pulok K Mukherjee, Director- School of Natural Product Studies, Jadavpur University, India


Bhushan PatwardhanKeynote Presentation

Drug and Formulation Discovery: Emerging Opportunities from Phytopharmaceuticals
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India


Formulation Development of Herbal Products to get Better Botanical Drug Product
Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd, India


Ayurvedic Nootropics for Enhanced Cognition and Protection from Neurodegenerative Diseases
Ashwini Godbole, Senior Assistant Professor, Institute of Transdisciplinary Health Sciences and Technology (TDU), India


Mining of Traditional Medicine for Drug Discovery and Development
Ashwinikumar Raut, Director, Clinical Research & Integrative Medicine, Kasturba Health Society - Medical Research Centre, India


Marketing Indian Traditional and Folk medicines and Practices : Need of the Hour
M Arulpitchai Narayanan, Chairman, Arma Medical Foundation, India


Panel Discussion : Traditional Medicines for Modern time: Challenges


Coffee Break and Networking in the Exhibition Area

Plenary Talk


Skype Talk: Contradiction of Precision Medicine Drugs
Stephen Naylor, Chairman & CEO, MaiHealth Inc & ReNeuroGen LLC , United States of America

Session III: Novel Strategies for Cancer Treatment- I / Session Chair: Dr Vijay Potluri


Engineering Reversal of Drug Resistance in Cancer Cells
Shantanu Chowdhury, Professor, CSIR- Institute of Genomics and Integrative Biology, India


Targeting Cancer at the Nuclear Pore
Asfar Azmi, Assistant Professor, Wayne State University School of Medicine, United States of America


Combining Selectivity and Sensitivity for High Confidence Targeted Peptide Quantitation at Low Levels
Russell Watts, Director - Business Development & Marketing, , EMEAI, AB Sciex, United Kingdom


End of First Day of Conference

Friday, 30 September 2016

Plenary Talk


Rakesh  KumarKeynote Presentation

Targeting Chromatin Remodeling and Bromodomain in Cancer
Rakesh Kumar, Distinguished Professor and National Chair in Cancer Research, Rajiv Gandhi Centre for Biotechnology, India

Session IV: Novel Strategies for Cancer Treatment- II / Session Chair Dr Siddhartha Roy


Ajay RanaKeynote Presentation

Mechanism Based Repurposing of Neurodegenerative Disease Drugs for Breast Cancer Treatment
Ajay Rana, Endowed Professor & Director of Research, University of Illinois at Chicago, United States of America


Synthesis, Characterization, DNA binding, Anti-Bacterial activity and DFT Calculation of [Ru(Phen)2OHA] and [Co(Phen)2OHA]ClO4 Complexes
Fahmida Khan, Professor & Head, National Institute of Technology, India


Predicting Clinical Response to Anticancer Drugs using an Ex Vivo Platform that Captures Patient Tumor Microenvironment
Ajith Kamath, Executive Director, Mitra Biotech, India


Coffee Break and Networking in the Exhibition Area


AB SciexTechnology Spotlight:
SCIEX & Danaher – Your Partner in Pharmaceutical Analysis
Russell Watts, Director - Business Development & Marketing, , EMEAI, AB Sciex

Session V: Therapies for Infectious & Neglected Tropical Diseases (Session Chair: Dr Saumitra Das, IISc)


Host Pathogen Interaction in Japanese Encephalitis Virus Infection: From Bench to Bedside
Anirban Basu, Senior Scientist, National Brain Research Center, India


Novel Drugs for Neglected Diseases
Utpal Tatu, Professor, Indian Institute of Science Bangalore, India


New Class of Glycopeptide Antibiotics: Strategies to Combat Acquired and Intrinsic Bacterial Resistance
Jayanta Haldar, Associate Professor, Jawaharlal Nehru Centre for Advanced Scientific Research, India


A Possible Strategy to Develop New Inhibitors of Arginase in Helicobacter Gastric Pathogens
Apurba Sau, Scientist, National Institute of Immunology, India


Identification of Potential Drug Molecules for Melioidosis Treatment
Thomas Antony, Research Director, Aurigene Discovery Technologies Limited, India


Poster Viewing


Lunch Break and Networking in the Exhibition Area

Session VI: Nutraceuticals- An Emerging Paradigm of Drug Discovery / Session Chair: Dr Ashwinikumar Raut


Atherosclerosis: Molecular Mechanisms, Current and Emerging Therapies, and the Potential Of Nutraceuticals In the Prevention/Treatment of this Disease
Dipak Ramji, Professor, Cardiff University, United Kingdom


Nutraceuticals as Antiobesogenic Lead Molecules
Suman Kapur, Senior Professor & Head , Birla Institute of Technology & Science, Pilani, India


Coffee Break and Networking in the Exhibition Area

SESSION VII: Current Enabling Technologies for Accelerated Drug Discovery / Session Chair: Dr Dipak Ramji


Monitoring Biological Methylation and its Role in Human Health
Said A Goueli, Clinical Professor and Senior Research Fellow, Promega Corporation, United States of America


Stem Cell and Gene Editing in Drug Discovery
Saumya Pant, Associate Research Director, Biocon Bristol-Myers Squibb India Pvt Ltd, India


Applications of Centrifugation & Automation Technology in Drug Discovery
Billy Asir, Product Specialist, Beckman Coulter India Pvt Ltd, India
Kalpesh Patil, , Beckman Coulter India Pvt Ltd, India


Panel Discussion: Drug Discovery and ADC - A Pharma & Biotech Perspective


Poster Award Presentation


Closing Remarks & Vote of Thanks


End of Conference

Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonDrug Discovery India 2016Drug Discovery India 2016 in